Ignite Creation Date:
2024-05-06 @ 7:36 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06062810
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-20
First Post:
2023-09-09
Brief Title:
Pharmacogenomics IND EXEMPT SNP Clinical Study - Crizotinib and Single Nucleotide Polymorphisms
Sponsor:
Han Xu MD PhD FAPCR Sponsor-Investigator IRB Chair
Organization:
Medicine Invention Design Inc
Organization Data
Organization:
Medicine Invention Design Inc
Class:
INDUSTRY
Study ID:
IND 168463 to be IND EXEMPT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Han Xu MD PhD FAPCR Sponsor-Investigator IRB Chair
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Han Xu MD PhD FAPCR Sponsor-Investigator IRB Chair
Responsible Party Title:
MD PhD FAPCR Sponsor-Investigator Medical Director Medical Monitor Safety Officer IORG Director IRB Chair
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Medicine Invention Design Inc
Old Name:
None
Old Organization:
None